Inventor · disambiguated record
Supriya Patel
Also filed as: PATEL SUPRIYA
13 granted patents·6 pending applications·135 citations·filing 2014–2025
91Inventor score
Files withREGENERON PHARMA19
Top patents by PatentIndex Score
19 records- 0197US9359437B2Antibodies comprising chimeric constant domainsREGENERON PHARMA·Filed 2014·Granted Jun 7, 2016·91 cites·21 claims
- 0296US12180272B2Antigen binding molecule formatsREGENERON PHARMA·Filed 2022·Granted Dec 31, 2024·2 cites·11 claims
- 0396US11708407B2Antigen binding molecule formatsREGENERON PHARMA·Filed 2022·Granted Jul 25, 2023·2 cites·26 claims
- 0496US10556952B2Heavy chain constant regions with reduced binding to Fc gamma receptorsREGENERON PHARMA·Filed 2016·Granted Feb 11, 2020·12 cites·24 claims
- 0595US11518807B2Heavy chain constant regions with reduced binding to Fc gamma receptorsREGENERON PHARMA·Filed 2019·Granted Dec 6, 2022·8 cites·40 claims
- 0695US10988537B2Antibodies comprising chimeric constant domainsREGENERON PHARMA·Filed 2018·Granted Apr 27, 2021·10 cites·20 claims
- 0792US12391753B2Antigen binding molecule formatsREGENERON PHARMA·Filed 2024·Granted Aug 19, 2025·0 cites·22 claims
- 0891US12215148B2Antigen binding molecule formatsREGENERON PHARMA·Filed 2020·Granted Feb 4, 2025·2 cites·25 claims
- 0991US2025333492A1Antigen binding molecule formatsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1090US12509514B2Antibodies comprising chimeric constant domainsREGENERON PHARMA·Filed 2021·Granted Dec 30, 2025·1 cites·32 claims
- 1190US12331109B2Antigen binding molecule formatsREGENERON PHARMA·Filed 2024·Granted Jun 17, 2025·0 cites·23 claims
- 1290US10106610B2Antibodies comprising chimeric constant domainsREGENERON PHARMA·Filed 2016·Granted Oct 23, 2018·7 cites·24 claims
- 1387US11965020B2Antigen binding molecule formatsREGENERON PHARMA·Filed 2023·Granted Apr 23, 2024·0 cites·24 claims
- 1487US2025289883A1Novel antigen binding molecule formatsREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1581US12509516B2Heavy chain constant regions with reduced binding to Fc gamma receptorsREGENERON PHARMA·Filed 2022·Granted Dec 30, 2025·0 cites·19 claims
- 1666US2024270836A1Il12 receptor agonists and methods of use thereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1765US2023382969A1Interleukin-2 proproteins and uses thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1863US2023391844A1Interleukin-2 proproteins and uses thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1953US2025297006A1Masked Multispecific Antigen-Binding Molecules with Cleavable LinkersREGENERON PHARMA·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Supriya Patel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →